Fagerberg J - Search Results

1

Functional HLA-DR T cell epitopes of CEA identified in patients with colorectal carcinoma immunized with the recombinant protein CEA.

Ullenhag GJ, Fagerberg J, Strigård K, Frödin JE, Mellstedt H. Ullenhag GJ, et al. Among authors: fagerberg j. Cancer Immunol Immunother. 2004 Apr;53(4):331-7. doi: 10.1007/s00262-003-0441-4. Epub 2003 Nov 7. Cancer Immunol Immunother. 2004. PMID: 14605762 Free PMC article.

2

Immunogenic regions of the GA733-2 tumour-associated antigen recognised by autoantibodies of patients with colorectal carcinoma.

Mosolits S, Steinitz M, Harmenberg U, Ruden U, Eriksson E, Mellstedt H, Fagerberg J. Mosolits S, et al. Among authors: fagerberg j. Cancer Immunol Immunother. 2002 Jun;51(4):209-18. doi: 10.1007/s00262-002-0272-8. Epub 2002 Apr 10. Cancer Immunol Immunother. 2002. PMID: 12012108 Free PMC article.

3

Vaccination with Ep-CAM protein or anti-idiotypic antibody induces Th1-biased response against MHC class I- and II-restricted Ep-CAM epitopes in colorectal carcinoma patients.

Mosolits S, Markovic K, Frödin JE, Virving L, Magnusson CG, Steinitz M, Fagerberg J, Mellstedt H. Mosolits S, et al. Among authors: fagerberg j. Clin Cancer Res. 2004 Aug 15;10(16):5391-402. doi: 10.1158/1078-0432.CCR-04-0425. Clin Cancer Res. 2004. PMID: 15328177

4

T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody.

Mosolits S, Markovic K, Fagerberg J, Frödin JE, Rezvany MR, Kiaii S, Mellstedt H, Jeddi-Tehrani M. Mosolits S, et al. Among authors: fagerberg j. Cancer Immunol Immunother. 2005 Jun;54(6):557-70. doi: 10.1007/s00262-004-0620-y. Epub 2004 Nov 27. Cancer Immunol Immunother. 2005. PMID: 15570423 Free PMC article.

5

Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies.

Ragnhammar P, Fagerberg J, Frödin JE, Wersäll P, Hansson LO, Mellstedt H. Ragnhammar P, et al. Among authors: fagerberg j. Cancer Immunol Immunother. 1995 Jun;40(6):367-75. doi: 10.1007/BF01525387. Cancer Immunol Immunother. 1995. PMID: 7627993 Free PMC article. Clinical Trial.

6

Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy?

Fagerberg J, Frödin JE, Ragnhammar P, Steinitz M, Wigzell H, Mellstedt H. Fagerberg J, et al. Cancer Immunol Immunother. 1994 Mar;38(3):149-59. doi: 10.1007/BF01525635. Cancer Immunol Immunother. 1994. PMID: 8124683 Free PMC article. Clinical Trial.

7

Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). I. May induction of ab1-reactive T cells and anti-anti-idiotypic antibodies (ab3) lead to tumor regression after mAb therapy?

Fagerberg J, Frödin JE, Wigzell H, Mellstedt H. Fagerberg J, et al. Cancer Immunol Immunother. 1993 Sep;37(4):264-70. doi: 10.1007/BF01518521. Cancer Immunol Immunother. 1993. PMID: 8348565 Free PMC article.

8

Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma--long-lasting, complete remissions can be induced.

Ragnhammar P, Fagerberg J, Frödin JE, Hjelm AL, Lindemalm C, Magnusson I, Masucci G, Mellstedt H. Ragnhammar P, et al. Among authors: fagerberg j. Int J Cancer. 1993 Mar 12;53(5):751-8. doi: 10.1002/ijc.2910530508. Int J Cancer. 1993. PMID: 8449598 Clinical Trial.

9

Humoral anti-idiotypic and anti-anti-idiotypic immune response in cancer patients treated with monoclonal antibody 17-1A.

Fagerberg J, Ragnhammar P, Liljefors M, Hjelm AL, Mellstedt H, Frödin JE. Fagerberg J, et al. Cancer Immunol Immunother. 1996 Feb;42(2):81-7. doi: 10.1007/s002620050255. Cancer Immunol Immunother. 1996. PMID: 8620524 Free PMC article. Clinical Trial.

10

Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen.

Samanci A, Yi Q, Fagerberg J, Strigård K, Smith G, Rudén U, Wahren B, Mellstedt H. Samanci A, et al. Among authors: fagerberg j. Cancer Immunol Immunother. 1998 Nov;47(3):131-42. doi: 10.1007/s002620050513. Cancer Immunol Immunother. 1998. PMID: 9829838 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters